Although nCRT combined with PD-L1 inhibitor therapy effectively promotes immune cell infiltration, we also observed that the presence of an immunosuppressive microenvironment might limit the functionality of immune cells, particularly through the actions of Treg cells, MDSCs, and immune checkpoint molecules within the tumor. This evidence concerns the gene CD274 and neoplasm.